Avanos Medical (AVNS) Interest Expenses (2013 - 2026)

Avanos Medical (AVNS) has 14 years of Interest Expenses data on file, last reported at $12.9 million in Q1 2026.

• For the quarter ending Q1 2026, Interest Expenses rose 25.24% year-over-year to $12.9 million; the trailing twelve-month figure through Mar 2026 stood at $12.9 million (up 25.24% YoY), and the FY2025 full-year result was $14.9 million, down 30.05% from the prior year.
• Interest Expenses grew to $12.9 million in Q1 2026, from $1.9 million in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $24.1 million in Q1 2023 to a low of $1.9 million in Q4 2025.
• A 5-year average of $16.0 million and a median of $22.0 million in 2023 frame the typical range for Interest Expenses.
• Across the five-year window, Interest Expenses jumped 296.67% in 2024 and tumbled 84.03% in 2025, its largest moves.
• Tracing AVNS's Interest Expenses over 5 years: stood at $3.0 million in 2022, then changed by 0.0% to $3.0 million in 2023, then jumped by 296.67% to $11.9 million in 2024, then plunged by 84.03% to $1.9 million in 2025, then surged by 578.95% to $12.9 million in 2026.
• Business Quant data shows AVNS's Interest Expenses at $12.9 million in Q1 2026, $1.9 million in Q4 2025, and $14.9 million in Q3 2025.